CRH Medical Corporation (NASDAQ:CRHM) Expected to Post Quarterly Sales of $31.27 Million

Analysts forecast that CRH Medical Corporation (NASDAQ:CRHM) will announce sales of $31.27 million for the current fiscal quarter, according to Zacks Investment Research. Three analysts have issued estimates for CRH Medical’s earnings, with the lowest sales estimate coming in at $31.10 million and the highest estimate coming in at $31.50 million. CRH Medical reported sales of $28.73 million during the same quarter last year, which indicates a positive year-over-year growth rate of 8.8%. The business is expected to announce its next quarterly earnings report on Wednesday, October 30th.

According to Zacks, analysts expect that CRH Medical will report full year sales of $128.04 million for the current fiscal year, with estimates ranging from $124.30 million to $131.00 million. For the next year, analysts anticipate that the firm will post sales of $142.64 million, with estimates ranging from $135.20 million to $151.80 million. Zacks’ sales calculations are an average based on a survey of research analysts that follow CRH Medical.

CRH Medical (NASDAQ:CRHM) last released its quarterly earnings data on Wednesday, July 31st. The company reported $0.02 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.01. The company had revenue of $30.48 million for the quarter, compared to analysts’ expectations of $29.50 million.

Separately, Bloom Burton raised shares of CRH Medical from an “accumulate” rating to a “buy” rating in a report on Thursday, August 1st.

Shares of CRHM traded down $0.01 during mid-day trading on Thursday, hitting $3.25. 11,331 shares of the company traded hands, compared to its average volume of 65,759. The business has a 50-day moving average price of $2.90. CRH Medical has a 1 year low of $2.51 and a 1 year high of $4.50.

CRH Medical Company Profile

CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid.

Featured Story: What strategies should day traders use to execute a trade?

Get a free copy of the Zacks research report on CRH Medical (CRHM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.